The CXC chemokines gamma interferon (IFN-γ)-inducible protein 10 and monokine induced by IFN-γ are released during severe melioidosis

被引:58
作者
Lauw, FN
Simpson, AJH
Prins, JM
van Deventer, SJH
Chaowagul, W
White, NJ
van der Poll, T
机构
[1] Univ Amsterdam, Acad Med Ctr, Lab Expt Internal Med, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands
[3] Mahidol Univ, Fac Trop Med, Bangkok, Thailand
[4] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 9DU, England
[5] Sappasitprasong Hosp, Ubon Ratchathani, Thailand
基金
英国惠康基金;
关键词
D O I
10.1128/IAI.68.7.3888-3893.2000
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Gamma interferon (IFN-gamma)-inducible protein 10 (IP-10) and monokine induced by IFN-gamma (Mig) are related CXC chemokines which bind to the CXCR3 receptor and specifically target activated T lymphocytes and natural killer (NK) cells. The production of IP-10 and Mig by various cell types in vitro is strongly dependent on IFN-gamma. To determine whether IP-10 and Mig are released during bacterial infection in humans, we measured plasma levels of IP-10 and Mig in patients with melioidosis, a severe gram-negative infection caused by Burkholderia pseudomallei. IP-10 and Mig were markedly elevated in patients with melioidosis on admission, particularly in blood culture-positive patients, and remained elevated during the 72-h study period. Levels of IP-10 and Mig showed a positive correlation with IFN-gamma concentrations and also correlated with clinical outcome. In whole blood stimulated with heat-killed B. pseudomallei, neutralization of IFN-gamma and tumor necrosis factor alpha (TNF-alpha) partly attenuated IP-10 and Mig release, while anti-interleukin-12 (IL-12) and anti-IL-18 had a synergistic effect. Stimulation with other bacteria or endotoxin also induced strong secretion of IP-10 and Mig. These data suggest that IP-10 and Mig are part of the innate immune response to bacterial infection. IP-10 and Mig may contribute to host defense in Th1-mediated host defense during infections by attracting CXCR3(+) Th1 cells to the site of inflammation.
引用
收藏
页码:3888 / 3893
页数:6
相关论文
共 35 条
[11]  
Gasperini S, 1999, J IMMUNOL, V162, P4928
[12]  
Goebeler M, 1998, J PATHOL, V184, P89, DOI 10.1002/(SICI)1096-9896(199801)184:1<89::AID-PATH975>3.0.CO
[13]  
2-Z
[14]   DETECTION OF A GAMMA-INTERFERON-INDUCED PROTEIN IP-10 IN PSORIATIC PLAQUES [J].
GOTTLIEB, AB ;
LUSTER, AD ;
POSNETT, DN ;
CARTER, DM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (03) :941-948
[15]   Intracellular survival of Burkholderia pseudomallei [J].
Jones, AL ;
Beveridge, TJ ;
Woods, DE .
INFECTION AND IMMUNITY, 1996, 64 (03) :782-790
[16]   THE EXPRESSION OF A GAMMA-INTERFERON INDUCED PROTEIN (IP-10) IN DELAYED IMMUNE-RESPONSES IN HUMAN-SKIN [J].
KAPLAN, G ;
LUSTER, AD ;
HANCOCK, G ;
COHN, ZA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (04) :1098-1108
[17]   Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon-gamma inducible protein-10 and monocyte chemotactic protein-1 [J].
Lahrtz, F ;
Piali, L ;
Nadal, D ;
Pfister, HW ;
Spanaus, KS ;
Baggiolini, M ;
Fontana, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (10) :2484-2489
[18]   Elevated plasma concentrations of interferon (IFN)-γ and the IFN-γ-inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis [J].
Lauw, FN ;
Simpson, AJH ;
Prins, JM ;
Smith, MD ;
Kurimoto, M ;
van Deventer, SJH ;
Speelman, P ;
Chaowagul, W ;
White, NJ ;
van der Poll, T .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (06) :1878-1885
[19]   HUMAN MIG CHEMOKINE - BIOCHEMICAL AND FUNCTIONAL-CHARACTERIZATION [J].
LIAO, F ;
RABIN, RL ;
YANNELLI, JR ;
KONIARIS, LG ;
VANGURI, P ;
FARBER, JM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05) :1301-1314
[20]   Chemokine receptor specific for IP10 and Mig: Structure, function, and expression in activated T-lymphocytes [J].
Loetscher, M ;
Gerber, B ;
Loetscher, P ;
Jones, SA ;
Piali, L ;
ClarkLewis, I ;
Baggiolini, M ;
Moser, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :963-969